Photo by sammoqadam from unsplash
Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients… Click to show full abstract
Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients with sever COVID‐19 have coexisting diabetic conditions, indicating the progression and outcome of COVID‐19 may relate to diabetes. However, it is still unclear whether diabetic treatment principles can be used for the treatment of COVID‐19.
Keywords:
clinical antidiabetic;
effects clinical;
agents sars;
potential effects;
sars cov;
antidiabetic agents
Journal Title: Journal of Diabetes
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Diabetes
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!